Back to URGN

Brookstone Capital Management → URGN

Brookstone Capital Management URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
2
Latest value
$246K
Q3 2026
Peak value
$246K
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$221K
Q3 2026$246K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$246K6.1K——
Q2 2026$221K6.0K——

Other funds holding URGN

Other Brookstone Capital Management positions

QQQ

INVESCO QQQ TR

$304.6M
VGES

VANGUARD INDEX FDS

$270.3M
VGES

VANGUARD INDEX FDS

$265M
SPY

SPDR S&P 500 ETF TR

$249.8M
VGES

VANGUARD INDEX FDS

$247.3M
VGES

VANGUARD INDEX FDS

$228.7M
SPY

STATE STR SPDR S&P 500 ETF T

$224.6M
NVDA

NVIDIA CORPORATION

$216M